Current market catalysts

RBC Capital Reiterates Outperform on HCA Healthcare, Maintains $435 Price Target

UBS Maintains Buy on Phillips 66, Raises Price Target to $300

'Canada In Talks to Sell Nuclear-Power Technology, LNG to Poland' - Bloomberg

Verisk Analytics shares are trading lower after Barclays lowered its price target on the stock from $275 to $225.

Dyne Therapeutics shares are trading lower. The company announced it will present additional one-year Phase 1/2 ACHIEVE trial data for zeleciment basivarsen in DM1 at the 31st WMS Congress and the 2026 AANEM Annual Meeting.

UBS Maintains Buy on HF Sinclair, Raises Price Target to $126

RBC Capital Reiterates Outperform on Colgate-Palmolive, Maintains $104 Price Target

UBS Maintains Buy on Valero Energy, Raises Price Target to $450

Beam Therapeutics shares are trading lower. The company announced updated clinical data from the Phase 1/2 trial evaluating BEAM-302 for alpha-1 antitrypsin deficiency.

Royalty Pharma shares are trading lower amid sympathy with Novartis after that company's pelacarsen phase III trial failed to reach its primary endpoint. The company had signed a $500 million funding agreement with Novartis partner Ionis that would have contributed pelacarsen royalties.

X-Energy shares are trading higher. Guggenheim reiterated the stock with a Buy rating and maintained a $57 price target.

If You Invested $100 In Bloom Energy Stock 5 Years Ago, You Would Have This Much Today

Bloom Energy (NYSE:BE) has outperformed the market over the past 5 years by 57.06% on an annualized basis producing an average annual return of 68.47%. Currently, Bloom Energy has a market capitalization of $80.82

Swvl Holdings shares are trading higher after the company announced that HSBC Bank has increased the limit on the company’s working capital facility by 110% to $1.4 million.

Enphase Energy shares are trading higher after the company announced that power modules for its IQ Solid-State Transformer are now being built in the U.S. to assemble and validate full-scale IQ SST racks.

Steve Eisman Owns AIG as Cantor Calls Stock ‘Really, Really Cheap’

Steve Eisman says he owns AIG as Cantor backs the insurer as a cheap “self-help story” with about 17% upside to its target.

Apple's Wednesday Event: Pricier iPhone 18 Pros and a $2,099 Foldable Expected

Bank of America maintains Buy on Apple with a $380 target before Wednesday's event, expecting a $2,099 foldable and $150-$200 Pro price hikes.

UBS Maintains Neutral on General Dynamics, Raises Price Target to $408

UBS Maintains Buy on Northrop Grumman, Raises Price Target to $704

UBS Upgrades EchoStar to Buy, Raises Price Target to $150

Inhibrx Biosciences shares are trading lower. The company announced primary endpoint results from the Phase 2 HexAgon study of INBRX-106, an OX40 agonist, combined with pembrolizumab versus pembrolizumab alone in PD-L1 positive head and neck squamous cell carcinoma.

Arbe Robotics Stock Rises After Level 3 Automated Driving Selection

Arbe Robotics Ltd. (NASDAQ:ARBE) shares are trading higher Tuesday after the company announced that a major automotive group selected its radar technology for a Level 3 automated driving program.

Cheche Group shares are trading lower after the company reported a year-over-year decrease in its H1 financial results.

UBS Upgrades Lockheed Martin to Buy, Raises Price Target to $674

RBC Capital Reiterates Sector Perform on Cencora, Maintains $330 Price Target

Boston Scientific shares are trading lower after the company disclosed that it's unlikely to meet its FY26 and Q3 adjusted EPS and net sales growth guidance following a previously announced cybersecurity incident that affected operations.

'Anthropic to stop Decart AI deal while investing in counts ahead of expected IPO' - Bloomberg

8-K filing — Federal Home Loan Bank of Topeka

Filed: 2026-09-08 AccNo: 0001325878-26-000178 Size: 169 KB Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

GoPro shares are trading lower. The company announced the issuance of $20 million convertible debenture to Yorkville, completing third and final closing under $50 million purchase agreement.

GrafTech International shares are trading higher after the company announced that it has informed customers of a minimum increase of 30% in graphite electrode prices, effective immediately for all open commercial negotiations.

RBC Capital Downgrades Biohaven to Sector Perform, Lowers Price Target to $19